# Catheter Ablation vs. Medical Therapy in Congested Hearts With AF

> **NCT02686749** · PHASE4 · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 4 (actual)

## Conditions studied

- Congestive Heart Failure
- Left Ventricular Failure
- Atrial Fibrillation

## Interventions

- **DEVICE:** Catheter Ablation
- **DRUG:** FDA approved anti arrhythmic drug

## Key facts

- **NCT ID:** NCT02686749
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2018-07-19
- **Final completion:** 2018-10-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** unable to reach enrollment goal
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686749, "Catheter Ablation vs. Medical Therapy in Congested Hearts With AF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02686749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*